| Product NDC: | 0008-1179 |
| Proprietary Name: | Torisel |
| Non Proprietary Name: | temsirolimus |
| Active Ingredient(s): | & nbsp; temsirolimus |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0008-1179 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022088 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070701 |
| Package NDC: | 0008-1179-01 |
| Package Description: | 1 KIT in 1 CARTON (0008-1179-01) * 25 mL in 1 VIAL, SINGLE-USE (0008-1279-01) * 1.8 mL in 1 VIAL, SINGLE-USE (0008-1125-01) |
| NDC Code | 0008-1179-01 |
| Proprietary Name | Torisel |
| Package Description | 1 KIT in 1 CARTON (0008-1179-01) * 25 mL in 1 VIAL, SINGLE-USE (0008-1279-01) * 1.8 mL in 1 VIAL, SINGLE-USE (0008-1125-01) |
| Product NDC | 0008-1179 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | temsirolimus |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20070701 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |